Advertisement
Screener

Orchestra BioMed Holdings, Inc. (OBIO) Cash Flow Breakdown

2.2 / 5 stars · 21/48 Roast Me

Orchestra BioMed Holdings, Inc. Cash Flow Breakdown

Cash flow breakdown shows where Orchestra BioMed Holdings, Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $48.96M went out.
  • Fiscal year ended 2025-12-31: from investing, $26.94M went out.
  • Fiscal year ended 2025-12-31: from financing, $88.33M came in.
  • Fiscal year ended 2025-12-31: change in cash, $12.43M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingDebt paid backNew debtStaff share taxNew shares soldNot split outChange in cash
2025-12-31-$48.96M-$26.94M-$1.55M$91.00K$89.79M*$12.43M
2024-12-31-$50.56M$13.09M$15.00M-$550.00K$240.00K$14.48M*-$8.30M
2023-12-31-$46.13M$10.69M-$10.85M$231.00K$56.83M*$10.78M
2022-12-31-$29.29M-$64.12M-$6.45M$10.00M$121.00K$99.58M*$9.85M
2021-12-31-$272.36K-$272.36K

Each quarter (3 month)

Quarter endRunning the businessFrom investingDividendsDebt paid backNew debtStaff share taxNew shares soldNot split outChange in cash
2026-06-30-$19.33M*-$23.31M*-$262.00K*$8.00K*$35.00M*
2026-03-31-$22.17M$10.32M-$354.00K$26.00K$5.86M*-$6.32M
2025-12-31-$2.27M*-$17.71M*-$468.00K*$0.00*$13.13M*
2025-09-30-$14.55M*-$38.58M*-$269.00K*$0.00*$76.67M*
2025-06-30-$15.53M*$16.36M*-$428.00K*$0.00*
2025-03-31-$16.62M$13.00M-$387.00K$91.00K-$3.91M
2024-12-31-$13.54M*-$3.75M*$51.00K*$13.90M*
2024-09-30-$13.70M*$557.00K*$0.00*$15.04M*
2024-06-30-$10.21M*$10.42M*$171.00K*
2024-03-31-$13.11M$5.86M$18.00K-$7.24M
2023-12-31-$10.97M*$33.15M*$153.00K*-$10.85M*
2023-09-30-$10.28M*$12.95M*$4.00K*
2023-06-30-$10.49M*$8.12M*$64.00K*
2023-03-31-$14.38M-$43.53M$10.00K$56.81M*-$1.09M
2022-12-31-$8.74M*-$63.38M*$0.00*$0.00*$0.00*$0.00*-$5.09M*
2022-09-30-$7.26M*-$224.00K*$0.00*$0.00*$4.00K*-$2.50M*
2022-06-30-$7.96M*-$474.00K*-$5.45M*$92.00K*$91.44M*
2022-03-31-$5.32M-$47.00K-$1.00M$25.00K$25.74M*$19.39M
2021-12-31-$28.84K*
2021-09-30-$128.01K*
2021-06-30-$39.14K*
2021-03-31-$76.37K-$76.37K

Similar stocks

Stock NameCountryMarket CapPE Ratio
SHOULDER INNOVATIONS, INC. (SI)United States$0.355B
Orthofix Medical Inc. (OFIX)$0.373B
Embecta Corp. (EMBC)United States$0.319B2.10
CARLSMED, INC. (CARL)United States$0.405B
TREACE MEDICAL CONCEPTS, INC. (TMCI)United States$0.297B-4.32
Mobia Medical, Inc. (MOBI)United States$0.293B
TriSalus Life Sciences, Inc. (TLSI)United States$0.283B-9.92
Cytosorbents Corp (CTSO)United States$0.274B-1.29
ORASURE TECHNOLOGIES INC (OSUR)United States$0.272B-6.26
Anika Therapeutics, Inc. (ANIK)United States$0.272B-51.71